Advertisement

Galectin Therapeutics Inc. GALT

Set alert

Price alert · GALT

All alert types
3.32 USD -0.20 -5.68%

At close · Oct 30

3.37 +0.05 +1.51%

After hours · Oct 30, 4:00 PM ET

Bid
3.32 × 2
Ask
3.34 × 2
3.27 Day range 3.54
2.08 52-week range 6.51
YTD
-20.19%
1 year
-34.52%
Open
3.52
Prev close
3.52
Mkt cap
334.82M
Vol
174.75K
Avg vol
294.60K
EPS
-0.43
P/E
0.00
Div yield
0.00%
More statistics
Low
3.27
High
3.54
Forward P/E
-0.53
Beta
0.63
Short ratio
42.37
Inst. own
15.77%
Dividend
0.00
Ex-div date
50-d avg
2.51
200-d avg
2.64
1y target
11.00

5D chart

Chart tools
Interval

Signals (118)
NameTimeAgo
SMA: BullishOct 30, 3:30 PM2 days ago
MACD: Buy SignalOct 30, 3:25 PM2 days ago
SMA: BullishOct 30, 3:20 PM2 days ago
RSI: OversoldOct 30, 3:15 PM2 days ago
RSI: OversoldOct 30, 2:55 PM2 days ago
RSI: OversoldOct 30, 2:10 PM2 days ago
MACD: Sell SignalOct 30, 2:00 PM2 days ago
MACD: Buy SignalOct 30, 12:25 PM2 days ago
MACD: Sell SignalOct 30, 11:45 AM2 days ago
SMA: BearishOct 30, 11:10 AM2 days ago
SMA: BearishOct 30, 11:10 AM2 days ago
SMA: BullishOct 30, 11:00 AM2 days ago
MACD: Buy SignalOct 30, 10:50 AM2 days ago
SMA: BullishOct 30, 10:40 AM2 days ago
RSI: OversoldOct 30, 10:10 AM2 days ago
RSI: OversoldOct 30, 10:00 AM2 days ago
RSI: OversoldOct 30, 9:50 AM2 days ago
MACD: Sell SignalOct 30, 9:45 AM2 days ago
SMA: BearishOct 30, 9:35 AM2 days ago
SMA: BearishOct 30, 9:35 AM2 days ago
SMA: BullishOct 29, 3:45 PM3 days ago
MACD: Buy SignalOct 29, 3:25 PM3 days ago
SMA: BearishOct 29, 1:45 PM3 days ago
SMA: BearishOct 29, 1:45 PM3 days ago
MACD: Sell SignalOct 29, 1:45 PM3 days ago
SMA: BullishOct 29, 1:40 PM3 days ago
SMA: BullishOct 29, 1:40 PM3 days ago
MACD: Buy SignalOct 29, 1:40 PM3 days ago
SMA: BullishOct 29, 1:00 PM3 days ago
SMA: BullishOct 29, 1:00 PM3 days ago
SMA: BearishOct 29, 12:30 PM3 days ago
SMA: BearishOct 29, 11:45 AM3 days ago
SMA: BearishOct 29, 11:45 AM3 days ago
MACD: Sell SignalOct 29, 11:45 AM3 days ago
MACD: Buy SignalOct 29, 11:35 AM3 days ago
SMA: BullishOct 29, 11:10 AM3 days ago
SMA: BullishOct 29, 11:10 AM3 days ago
SMA: BearishOct 29, 10:45 AM3 days ago
SMA: BearishOct 29, 10:35 AM3 days ago
SMA: BullishOct 29, 10:20 AM3 days ago
MACD: Sell SignalOct 29, 10:10 AM3 days ago
SMA: BearishOct 29, 9:55 AM3 days ago
RSI: OverboughtOct 29, 9:30 AM3 days ago
MACD: Buy SignalOct 28, 3:45 PM4 days ago
RSI: OverboughtOct 28, 3:45 PM4 days ago
SMA: BullishOct 28, 3:40 PM4 days ago
MACD: Sell SignalOct 28, 3:35 PM4 days ago
SMA: BullishOct 28, 3:20 PM4 days ago
SMA: BearishOct 28, 3:10 PM4 days ago
RSI: OverboughtOct 28, 2:50 PM4 days ago
RSI: OverboughtOct 28, 2:40 PM4 days ago
SMA: BullishOct 28, 2:15 PM4 days ago
SMA: BullishOct 28, 2:15 PM4 days ago
SMA: BullishOct 28, 1:45 PM4 days ago
MACD: Buy SignalOct 28, 1:45 PM4 days ago
MACD: Sell SignalOct 28, 12:05 PM4 days ago
SMA: BearishOct 28, 12:00 PM4 days ago
SMA: BullishOct 28, 11:15 AM4 days ago
MACD: Buy SignalOct 28, 11:15 AM4 days ago
MACD: Sell SignalOct 28, 11:10 AM4 days ago
MACD: Buy SignalOct 28, 10:30 AM4 days ago
SMA: BullishOct 28, 10:25 AM4 days ago
SMA: BullishOct 28, 10:25 AM4 days ago
SMA: BearishOct 28, 10:05 AM4 days ago
SMA: BearishOct 28, 10:05 AM4 days ago
MACD: Sell SignalOct 28, 10:05 AM4 days ago
MACD: Buy SignalOct 28, 10:00 AM4 days ago
SMA: BullishOct 28, 9:55 AM4 days ago
SMA: BullishOct 28, 9:55 AM4 days ago
SMA: BearishOct 28, 9:30 AM4 days ago
SMA: BearishOct 27, 3:55 PM5 days ago
MACD: Sell SignalOct 27, 3:55 PM5 days ago
RSI: OverboughtOct 27, 3:30 PM5 days ago
RSI: OverboughtOct 27, 3:15 PM5 days ago
RSI: OverboughtOct 27, 2:50 PM5 days ago
MACD: Buy SignalOct 27, 2:45 PM5 days ago
MACD: Sell SignalOct 27, 2:35 PM5 days ago
MACD: Buy SignalOct 27, 2:05 PM5 days ago
MACD: Sell SignalOct 27, 1:55 PM5 days ago
MACD: Buy SignalOct 27, 1:35 PM5 days ago
SMA: BearishOct 27, 12:10 PM5 days ago
MACD: Sell SignalOct 27, 12:10 PM5 days ago
RSI: OverboughtOct 27, 11:35 AM5 days ago
SMA: BullishOct 27, 10:30 AM5 days ago
SMA: BullishOct 27, 10:30 AM5 days ago
MACD: Buy SignalOct 27, 10:30 AM5 days ago
SMA: BearishOct 27, 10:10 AM5 days ago
SMA: BearishOct 27, 10:10 AM5 days ago
MACD: Sell SignalOct 27, 10:10 AM5 days ago
SMA: BullishOct 27, 10:05 AM5 days ago
MACD: Buy SignalOct 27, 9:50 AM5 days ago
SMA: BearishOct 27, 9:45 AM5 days ago
SMA: BullishOct 27, 9:40 AM5 days ago
SMA: BullishOct 27, 9:40 AM5 days ago
SMA: BearishOct 26, 3:55 PM6 days ago
SMA: BearishOct 26, 3:40 PM6 days ago
SMA: BullishOct 26, 3:35 PM6 days ago
SMA: BullishOct 26, 3:10 PM6 days ago
SMA: BearishOct 26, 3:00 PM6 days ago
SMA: BullishOct 26, 2:50 PM6 days ago
MACD: Sell SignalOct 26, 2:15 PM6 days ago
MACD: Buy SignalOct 26, 2:10 PM6 days ago
SMA: BullishOct 26, 2:05 PM6 days ago
SMA: BearishOct 26, 2:00 PM6 days ago
SMA: BullishOct 26, 1:40 PM6 days ago
SMA: BullishOct 26, 1:40 PM6 days ago
SMA: BearishOct 26, 1:35 PM6 days ago
SMA: BearishOct 26, 1:05 PM6 days ago
SMA: BullishOct 26, 12:55 PM6 days ago
SMA: BullishOct 26, 12:55 PM6 days ago
SMA: BearishOct 26, 12:50 PM6 days ago
SMA: BearishOct 26, 12:50 PM6 days ago
MACD: Sell SignalOct 26, 12:50 PM6 days ago
MACD: Buy SignalOct 26, 12:30 PM6 days ago
SMA: BullishOct 26, 12:00 PM6 days ago
SMA: BearishOct 26, 11:30 AM6 days ago
SMA: BullishOct 26, 11:15 AM6 days ago
SMA: BearishOct 26, 11:10 AM6 days ago

Key statistics

Market cap
55.86M
Enterprise value
241.35M
Trailing P/E
0.00
Forward P/E
-0.53
PEG ratio
0.00
Price / sales
0.00
Price / book
0.00
EPS (TTM)
-0.73
Beta
0.63
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
-20.36M
Total cash
25.60M
Total debt
93.47M
Return on equity
0.00%
Shares outstanding
62.76M
Short % of float
18.41%
50-day average
2.51
200-day average
2.64

Analyst view

Consensus: none

Price target (mean) 11.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy0
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
GALT Revenue — quarterly 0
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
GALT Net income — quarterly -9.11M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
GALT EPS — quarterly -0.14
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

GALT recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 14, 2024Sep 1, 2024-0.20-0.18+0.02+10.00%
Aug 13, 2024Jun 1, 2024-0.16-0.20-0.04-25.00%
May 15, 2024Mar 1, 2024-0.16-0.19-0.03-18.75%
Mar 29, 2024Dec 1, 2023-0.16-0.160.000.00%
Nov 13, 2023Sep 1, 2023-0.16-0.24-0.08-50.00%
Aug 14, 2023Jun 1, 2023-0.21-0.15+0.06+28.57%

Upgrades / downgrades

GALT analyst upgrades and downgrades
DateFirmActionFromTo
Nov 15, 2024HC Wainwright & Co.reitBuyBuy
Aug 16, 2024HC Wainwright & Co.reitBuyBuy
Apr 9, 2024HC Wainwright & Co.reitBuyBuy
Apr 1, 2024HC Wainwright & Co.reitBuyBuy
Aug 15, 2023HC Wainwright & Co.reitBuyBuy
May 17, 2023HC Wainwright & Co.reitBuyBuy

About Galectin Therapeutics Inc.

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, that is in Phase 2b/3 clinical trial, to prevent esophageal varices in patient with non-alcoholic steatohepatitis (NASH) cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and head and neck squamous cell carcinoma. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and develop small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

Your note

Sign in to keep a note on GALT — it syncs with the Stock Master app.

Insider holders

GALT insider holders
InsiderRelationLatest transactionDateShares held
CZIRR JAMES CBeneficial Owner of more than 10% of a Class of SecuritySaleApr 22, 20240
ELDRED KARY N.DirectorPurchaseOct 22, 202454,638
FREEMAN KEVIN DDirectorPurchaseOct 16, 2024132,832
LEWIS JOELChief Executive OfficerPurchaseApr 23, 20240
UIHLEIN RICHARD EDirector and Beneficial Owner of more than 10% of a Class of SecurityStock Award(Grant)Jan 23, 202410,296,500
ZORDANI RICHARD A. JRDirectorPurchaseAug 22, 20240

Institution ownership

GALT institution ownership
Holder% heldSharesValueReported
Vanguard Group Inc3.40%2,134,2051.90MSep 29, 2024
Blackrock Inc.2.56%1,607,1241.43MSep 29, 2024
Osaic Holdings Inc1.88%1,182,0951.05MSep 29, 2024
Geode Capital Management, LLC1.37%862,542767.75KSep 29, 2024
Commonwealth Equity Services, LLC0.77%483,264430.15KSep 29, 2024
Wealthspire Advisors, LLC0.63%398,374354.59KSep 29, 2024

Fund ownership

GALT fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund1.99%1,247,5621.11MSep 29, 2024
Vanguard Extended Market Index Fund1.07%670,160596.51KSep 29, 2024
iShares Russell 2000 ETF0.59%372,101331.21KOct 30, 2024
Fidelity Extended Market Index Fund0.44%278,527247.92KOct 30, 2024
Fidelity Small Cap Index Fund0.32%198,844176.99KAug 30, 2024
iShares Russell 2000 Growth ETF0.17%107,35295.55KOct 30, 2024
Advertisement